A dialogue with Glen de Vries, president of Medidata, and Ken Banta, founder of the Vanguard Group for Leadership.
On October 24-25, over 1,000 life science professionals will converge in New York at Spring Street Studios. And we want YOU to present.
"How many of your colleagues can describe and visualize the actual patient experience?"
PhaseBio—a clinical-stage biopharma company developing improved biotherapeutics for orphan diseases, with an initial focus on cardiopulmonary disorders—has the distinction of being Medidata's 1,000th customer.
Deploying wearable devices in global clinical studies offer the promise of better, more cost-efficient data for clinical trial sponsors, but what about the infrastructure behind the massive volumes of data? Unreliable cell network coverage in certain markets? Wearables’ ability to collect reliable, validated endpoint data?